Leukemia  >>  oxycodone controlled release  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
oxycodone controlled release / Generic mfg.
NCT00726830: Methadone, Morphine, or Oxycodone in Treating Pain in Patients With Cancer

Terminated
N/A
1
US
methadone hydrochloride, methadone, dolophine, methadose, morphine sulfate, oxycodone hydrochloride, oxycodone, ETH-Oxydose, DSC, OxyIR, OxyContin, Roxicodone
M.D. Anderson Cancer Center, National Cancer Institute (NCI)
Brain and Central Nervous System Tumors, Chronic Myeloproliferative Disorders, Leukemia, Lymphoma, Lymphoproliferative Disorder, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms, Pain, Precancerous Condition, Unspecified Adult Solid Tumor, Protocol Specific
09/10
10/10

Download Options